RevistaLab
The Life Science Real Estate (LSRE) sector, like many other commercial real estate sectors, has seen transaction activity slow in recent years. Higher interest rates have created an uneasy investing and lending environment. The LSRE sector . . .
Preliminary data shows a total of $3.16 billion for life science sales in 2024, totaling 5.17 million square feet. This is equivalent to about half of the volume recorded in 2023. Yearly volume has maintained a consistent decline since 2022, and 2024 has yet to show a clear reversal. On a positive note, if . . .
It will come as no surprise to report that transaction activity was rather slow in 2Q24. Volume has been on a downward trend since the end of 2022, and the recent quarter is no exception. While the market sentiment has been consistent over the past year, it is crucial to keep tabs, especially as we approach a potential pivot point. Just under
Life science real estate is clustered around the major markets. Boston, San Francisco, and San Diego are ahead of the curve when it comes fostering a life science ecosystem. It is interesting to compare these markets to the larger upcoming clusters, as well as the rest of the U.S. One aspect we can compare is . . .
RevistaLab.com recently held its 4th quarter life science real estate update. Revista principals, Hilda Martin and Mike Hargrave presented RevistaLab data on construction trends, transactions, occupancies, supply/demand fundamentals across the …
Life Science real estate transaction volume picked up at the end of 2023, according to newly released data from www.revistalab.com.
Over the past few years, a spotlight has been on the Life Science industry (and the real estate that serves it) due to the pandemic and the rush to create …